Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantSection Navigation
Section Navigation
- Module 6 Overview
Key Populations - 0%Lesson 1
HIV in Infants and ChildrenActivities- 0%Lesson 2
HIV in Adolescents and Young AdultsActivities- 0%Lesson 3
HIV in WomenActivities- 0%Lesson 4
HIV in Older AdultsActivities- 0%Lesson 5
HIV and CorrectionsLesson 2. HIV in Adolescents and Young Adults
Learning Objective Performance Indicators
- Explain current epidemiologic features of HIV in adolescents and young adults in the United States
- Discuss factors that increase the risk of adolescents and young adults acquiring HIV
- List appropriate antiretroviral regimens for adolescents and young adults
- Summarize indications and recommendations for HIV preexposure prophylaxis in adolescents and young adults
- Describe approaches for successful transition of young adults with HIV into adult primary care HIV practice settings
About this Lesson
Learning Objective Performance Indicators
- Explain current epidemiologic features of HIV in adolescents and young adults in the United States
- Discuss factors that increase the risk of adolescents and young adults acquiring HIV
- List appropriate antiretroviral regimens for adolescents and young adults
- Summarize indications and recommendations for HIV preexposure prophylaxis in adolescents and young adults
- Describe approaches for successful transition of young adults with HIV into adult primary care HIV practice settings
Activities in this Lesson
- Quick ReferenceHIV in Adolescents and Young Adults Core Concepts
- Introduction
- Epidemiology of HIV in Adolescents and Young Adults
- Testing, Linkage to Care, and Retention in Care
- Clinical and Laboratory Monitoring
- Antiretroviral Therapy for Adolescents with HIV
- Adherence with Antiretroviral Therapy
- HIV Preexposure Prophylaxis (PrEP) for Adolescents
- Immunizations for Adolescents with HIV
- Adolescent Sexuality and Reproductive Health
- Special Considerations for Youth with Perinatal HIV
- Transitioning to Adult Care
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Health Resources and Services Administration (HRSA)
Created at
University of Washington
An AETC Program
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE approved byOregon Nurses Association
Copyright © 2025 National HIV Curriculum
The National HIV Curriculum is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1,172,990 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-625831b2-2025-02-13-011703